1. Home
  2. PBMWW vs RVLV Comparison

PBMWW vs RVLV Comparison

Compare PBMWW & RVLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBMWW
  • RVLV
  • Stock Information
  • Founded
  • PBMWW N/A
  • RVLV 2003
  • Country
  • PBMWW Canada
  • RVLV United States
  • Employees
  • PBMWW 10
  • RVLV N/A
  • Industry
  • PBMWW
  • RVLV Catalog/Specialty Distribution
  • Sector
  • PBMWW
  • RVLV Consumer Discretionary
  • Exchange
  • PBMWW Nasdaq
  • RVLV Nasdaq
  • Market Cap
  • PBMWW N/A
  • RVLV 2.6B
  • IPO Year
  • PBMWW N/A
  • RVLV 2019
  • Fundamental
  • Price
  • PBMWW $0.01
  • RVLV $33.29
  • Analyst Decision
  • PBMWW
  • RVLV Buy
  • Analyst Count
  • PBMWW 0
  • RVLV 16
  • Target Price
  • PBMWW N/A
  • RVLV $27.09
  • AVG Volume (30 Days)
  • PBMWW N/A
  • RVLV 954.9K
  • Earning Date
  • PBMWW N/A
  • RVLV 02-25-2025
  • Dividend Yield
  • PBMWW N/A
  • RVLV N/A
  • EPS Growth
  • PBMWW N/A
  • RVLV 29.44
  • EPS
  • PBMWW N/A
  • RVLV 0.57
  • Revenue
  • PBMWW N/A
  • RVLV $1,093,961,000.00
  • Revenue This Year
  • PBMWW N/A
  • RVLV $6.76
  • Revenue Next Year
  • PBMWW N/A
  • RVLV $8.68
  • P/E Ratio
  • PBMWW N/A
  • RVLV $58.67
  • Revenue Growth
  • PBMWW N/A
  • RVLV 2.23
  • 52 Week Low
  • PBMWW N/A
  • RVLV $13.96
  • 52 Week High
  • PBMWW N/A
  • RVLV $39.58
  • Technical
  • Relative Strength Index (RSI)
  • PBMWW N/A
  • RVLV 47.67
  • Support Level
  • PBMWW N/A
  • RVLV $32.33
  • Resistance Level
  • PBMWW N/A
  • RVLV $34.37
  • Average True Range (ATR)
  • PBMWW 0.00
  • RVLV 1.69
  • MACD
  • PBMWW 0.00
  • RVLV -0.45
  • Stochastic Oscillator
  • PBMWW 0.00
  • RVLV 20.42

About PBMWW Psyence Biomedical Ltd. Warrant

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

About RVLV Revolve Group Inc.

The Revolve Group is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2023 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the US, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 20% of sales from private-label offerings, while focusing on building an inventory of unique products from emerging fashion brands with less than $10 million in annual sales.

Share on Social Networks: